PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12016742::ACT015701

GI

Evidence text

Paper-level observation

At day 17 post‐treatment initiation, we observed a significant reduction in the individual tumor weight of mice treated with StCl‐GI_GII (P = 0.0086) or StCl‐GI_GII + αPD‐1 (P = 0.0092) (Figure S18d).
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Antibacterial
Measure
percent_inhibition
Comparator
=
Raw observation
P = 0.0086 vs PBS
Normalized measurement
=0.0086
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
EGSRNQDWL
Standardization
ready simple

Source publication

Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma

Advanced Materials · 2025

DOI 10.1002/adma.202417348 PMC12016742
Parent mention

Related peptide identities

PEPDIA-PLP-000563

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.